Rare disease consortium is good news for NC gene therapy companies
RESEARCH TRIANGLE PARK - The nearly 30 million Americans who suffer from rare diseases have received some good news. The National Institutes of Health, the U.S.
Stay updated with breaking news from Jonil Rutter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RESEARCH TRIANGLE PARK - The nearly 30 million Americans who suffer from rare diseases have received some good news. The National Institutes of Health, the U.S.
A new national public/private consortium designed to boost the development of gene therapies also holds promise for North Carolina, as a major global leader in cell and gene therapies.
While there are approximately 7,000 rare diseases, only two heritable diseases currently have FDA-approved gene therapies.
The National Institutes of Health, U.S. Food and Drug Administration, 10 pharmaceutical companies and five non-profit organizations have partnered to
A new, retrospective study of medical and insurance records indicates health care costs for people with a rare disease have been underestimated and are three to five times greater than the costs for people without a rare disease.